000 | 01916 a2200493 4500 | ||
---|---|---|---|
005 | 20250518070902.0 | ||
264 | 0 | _c20200720 | |
008 | 202007s 0 0 eng d | ||
022 | _a1533-4023 | ||
024 | 7 |
_a10.1097/FJC.0000000000000726 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDong, Fang | |
245 | 0 | 0 |
_aChrysin Alleviates Chronic Hypoxia-Induced Pulmonary Hypertension by Reducing Intracellular Calcium Concentration in Pulmonary Arterial Smooth Muscle Cells. _h[electronic resource] |
260 |
_bJournal of cardiovascular pharmacology _c11 2019 |
||
300 |
_a426-435 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntihypertensive Agents _xpharmacology |
650 | 0 | 4 |
_aBone Morphogenetic Protein 4 _xmetabolism |
650 | 0 | 4 |
_aCalcium _xmetabolism |
650 | 0 | 4 |
_aCalcium Signaling _xdrug effects |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aFlavonoids _xpharmacology |
650 | 0 | 4 |
_aHypertension, Pulmonary _xetiology |
650 | 0 | 4 |
_aHypoxia _xcomplications |
650 | 0 | 4 |
_aHypoxia-Inducible Factor 1, alpha Subunit _xmetabolism |
650 | 0 | 4 |
_aMuscle, Smooth, Vascular _xdrug effects |
650 | 0 | 4 |
_aMyocytes, Smooth Muscle _xdrug effects |
650 | 0 | 4 |
_aPulmonary Artery _xdrug effects |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aTRPC Cation Channels _xmetabolism |
650 | 0 | 4 |
_aVascular Remodeling _xdrug effects |
650 | 0 | 4 |
_aVentricular Function, Right _xdrug effects |
650 | 0 | 4 |
_aVentricular Pressure _xdrug effects |
650 | 0 | 4 |
_aVentricular Remodeling _xdrug effects |
700 | 1 | _aZhang, Jun | |
700 | 1 | _aZhu, Shun | |
700 | 1 | _aLan, Ting | |
700 | 1 | _aYang, Jinbo | |
700 | 1 | _aLi, Linqing | |
773 | 0 |
_tJournal of cardiovascular pharmacology _gvol. 74 _gno. 5 _gp. 426-435 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/FJC.0000000000000726 _zAvailable from publisher's website |
999 |
_c30310880 _d30310880 |